Royal Bank of Canada’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Buy |
8,421
+8,375
| +18,207% | +$12.9K | ﹤0.01% | 6015 |
|
|
2025
Q1 | $0 | Sell |
46
-727
| -94% | – | ﹤0.01% | 6372 |
|
|
2024
Q4 | $2K | Buy |
773
+715
| +1,233% | +$1.85K | ﹤0.01% | 6186 |
|
|
2024
Q3 | $0 | Sell |
58
-4,189
| -99% | – | ﹤0.01% | 6312 |
|
|
2024
Q2 | $5K | Buy |
4,247
+1,282
| +43% | +$1.51K | ﹤0.01% | 6126 |
|
|
2024
Q1 | $4K | Sell |
2,965
-20,423
| -87% | -$27.6K | ﹤0.01% | 6026 |
|
|
2023
Q4 | $25K | Buy |
23,388
+10,083
| +76% | +$10.8K | ﹤0.01% | 5696 |
|
|
2023
Q3 | $92K | Buy |
13,305
+7,335
| +123% | +$50.7K | ﹤0.01% | 4949 |
|
|
2023
Q2 | $62K | Buy |
5,970
+1,435
| +32% | +$14.9K | ﹤0.01% | 5213 |
|
|
2023
Q1 | $36K | Sell |
4,535
-2,969
| -40% | -$23.6K | ﹤0.01% | 5402 |
|
|
2022
Q4 | $117K | Buy |
7,504
+6,673
| +803% | +$104K | ﹤0.01% | 4865 |
|
|
2022
Q3 | $13K | Buy |
831
+484
| +139% | +$7.57K | ﹤0.01% | 5801 |
|
|
2022
Q2 | $5K | Sell |
347
-2,790
| -89% | -$40.2K | ﹤0.01% | 6157 |
|
|
2022
Q1 | $54K | Sell |
3,137
-7,590
| -71% | -$131K | ﹤0.01% | 5547 |
|
|
2021
Q4 | $156K | Buy |
10,727
+5,581
| +108% | +$81.2K | ﹤0.01% | 5059 |
|
|
2021
Q3 | $93K | Buy |
5,146
+2,172
| +73% | +$39.3K | ﹤0.01% | 5240 |
|
|
2021
Q2 | $52K | Sell |
2,974
-541
| -15% | -$9.46K | ﹤0.01% | 5520 |
|
|
2021
Q1 | $89K | Buy |
3,515
+1,621
| +86% | +$41K | ﹤0.01% | 5051 |
|
|
2020
Q4 | $12K | Buy |
1,894
+1,520
| +406% | +$9.63K | ﹤0.01% | 5733 |
|
|
2020
Q3 | $1K | Sell |
374
-4,035
| -92% | -$10.8K | ﹤0.01% | 5883 |
|
|
2020
Q2 | $7K | Sell |
4,409
-3,555
| -45% | -$5.64K | ﹤0.01% | 5458 |
|
|
2020
Q1 | $8K | Buy |
7,964
+3,966
| +99% | +$3.98K | ﹤0.01% | 5382 |
|
|
2019
Q4 | $7K | Buy |
3,998
+3,353
| +520% | +$5.87K | ﹤0.01% | 5638 |
|
|
2019
Q3 | $1K | Sell |
645
-3,000
| -82% | -$4.65K | ﹤0.01% | 5704 |
|
|
2019
Q2 | $8K | Sell |
3,645
-1,261
| -26% | -$2.77K | ﹤0.01% | 5228 |
|
|
2019
Q1 | $29K | Sell |
4,906
-89
| -2% | -$526 | ﹤0.01% | 4733 |
|
|
2018
Q4 | $37K | Sell |
4,995
-2,059
| -29% | -$15.3K | ﹤0.01% | 4577 |
|
|
2018
Q3 | $102K | Buy |
7,054
+452
| +7% | +$6.54K | ﹤0.01% | 4259 |
|
|
2018
Q2 | $132K | Buy |
6,602
+85
| +1% | +$1.7K | ﹤0.01% | 4075 |
|
|
2018
Q1 | $114K | Buy |
6,517
+5,531
| +561% | +$96.8K | ﹤0.01% | 4033 |
|
|
2017
Q4 | $24K | Sell |
986
-1,219
| -55% | -$29.7K | ﹤0.01% | 4781 |
|
|
2017
Q3 | $57K | Buy |
2,205
+2,191
| +15,650% | +$56.6K | ﹤0.01% | 4599 |
|
|
2017
Q2 | $0 | Sell |
14
-312
| -96% | – | ﹤0.01% | 5773 |
|
|
2017
Q1 | $10K | Sell |
326
-142
| -30% | -$4.36K | ﹤0.01% | 5271 |
|
|
2016
Q4 | $13K | Buy |
+468
| New | +$13K | ﹤0.01% | 5207 |
|